Syneos Health

Syneos Health delivers fully integrated biopharmaceutical solutions, combining clinical development services with commercialization expertise. The company operates as a comprehensive contract research organization (CRO) and contract commercial organization (CCO), providing services that span the entire product lifecycle from clinical trials through market access and commercial launch, aiming to optimize the development and delivery of new therapies.

The modern Syneos Health was formed through the 2017 merger of INC Research and inVentiv Health. INC Research was initially founded in 1998 by James T. O'Brien, an insight driven by the growing need for specialized clinical research services to support pharmaceutical development. This consolidation brought together deep capabilities in both clinical research and commercial strategies.

Syneos Health serves biopharmaceutical companies globally, assisting them in navigating complex regulatory landscapes and bringing innovative treatments to patients more efficiently. The company’s vision centers on accelerating the success of its customers by streamlining the journey from scientific discovery to patient care, ultimately advancing health outcomes worldwide.